Nicholas Moore focuses on Internal medicine, Confidence interval, Pharmacology, Pharmacovigilance and Odds ratio. Nicholas Moore has included themes like Cardiology, Ibuprofen and Polysomnography in his Internal medicine study. His research integrates issues of Epidemiology, Surgery, Case-control study, Meta-analysis and Placebo in his study of Confidence interval.
Nicholas Moore has researched Pharmacology in several fields, including Alternative medicine and Clinical trial. His Pharmacovigilance research incorporates elements of Dabigatran, Marketing, Concomitant and Mortality rate. Nicholas Moore interconnects Rivaroxaban, Occupational safety and health and Adverse Event Reporting System in the investigation of issues within Odds ratio.
His main research concerns Internal medicine, Cohort study, Pharmacology, Pharmacoepidemiology and Cohort. He works mostly in the field of Internal medicine, limiting it down to topics relating to Surgery and, in certain cases, Clinical trial, as a part of the same area of interest. His studies deal with areas such as Dabigatran, Rivaroxaban, Atrial fibrillation and Hazard ratio as well as Cohort study.
His research in Drug and Adverse effect are components of Pharmacology. His Pharmacoepidemiology study frequently draws connections between related disciplines such as Pharmacovigilance. His work in Confidence interval is not limited to one particular discipline; it also encompasses Odds ratio.
His primary areas of investigation include Internal medicine, Cohort study, Pharmacoepidemiology, Cohort and Confidence interval. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Oncology. His Cohort study research integrates issues from Rivaroxaban, Surgery, Emergency medicine, Atrial fibrillation and Pediatrics.
His Pharmacoepidemiology research focuses on subjects like Drug, which are linked to Observational study. His Cohort study incorporates themes from Statin and Colorectal cancer. His research on Confidence interval often connects related topics like Odds ratio.
His primary areas of study are Internal medicine, Cohort study, Confidence interval, Pharmacoepidemiology and Surgery. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology and Diclofenac. His study in Cohort study is interdisciplinary in nature, drawing from both Acute coronary syndrome, FOLFIRI, Hazard ratio, Colorectal cancer and Cohort.
The study incorporates disciplines such as Odds ratio, Risperidone and Sudden cardiac death in addition to Confidence interval. His Pharmacoepidemiology research is multidisciplinary, incorporating perspectives in Heart failure, Medical diagnosis, Intensive care medicine, Medical emergency and Apixaban. The Surgery study combines topics in areas such as Relative risk and Cetuximab.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia
Stephane Picard;Karine Titier;Gabriel Etienne;Emmanuelle Teilhet.
Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care.
M. Molimard;C. Raherison;S. Lignot;F. Depont.
Journal of Aerosol Medicine-deposition Clearance and Effects in The Lung (2003)
Frequency and cost of serious adverse drug reactions in a department of general medicine.
Nicholas Moore;Dominique Lecointre;Catherine Noblet;Michel Mabille.
British Journal of Clinical Pharmacology (1998)
Fatigue, sleep restriction and driving performance
Pierre Philip;Patricia Sagaspe;Nicholas Moore;Jacques Taillard.
Accident Analysis & Prevention (2005)
Fatigue, sleepiness, and performance in simulated versus real driving conditions.
Pierre Philip;Patricia Sagaspe;Jacques Taillard;Cedric Valtat.
Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder.
Nicholas Moore;Hélène Verdoux;Bruno Fantino.
International Clinical Psychopharmacology (2005)
Age, performance and sleep deprivation.
Pierre Philip;Jacques Taillard;Patricia Sagaspe;Cedric Valtat.
Journal of Sleep Research (2004)
The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.
Julien Bezin;Julien Bezin;Mai Duong;Régis Lassalle;Cécile Droz.
Pharmacoepidemiology and Drug Safety (2017)
Adverse drug reaction monitoring: doing it the French way.
N. Moore;G. Paux;B. Begaud;M. Biour.
The Lancet (1985)
ACAMPROSATE APPEARS TO DECREASE ALCOHOL INTAKE IN WEANED ALCOHOLICS
J. P. Lhuintre;N. Moore;G. Tran;L. Steru.
Alcohol and Alcoholism (1990)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: